14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:RXII
Delisted

RXI Pharmaceuticals Corporation Fund Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.82
+0 (+0%)
At Close: Dec 08, 2023
Forecast Signals Historical Prices Predictions Profile
Currently predicting for Tue, 7 May 2024

RXII Predictions History

7 years ago
 JS predicted that RXII for 2017-03-31 is going $0.83 (-89.74%)

7 years ago
 StockInvest predicted that RXII for 2016-08-15 is going $2.35 (-89.96%)

Click to get the best stock tips daily for free!

About RXI Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation, a clinical-stage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma... RXII Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT